European Archives - Page 1159 of 1344 - European Medical Journal

Editor’s Pick: 3D Printing for Biomedical Applications: Where Are We Now?

Three-dimensional (3D) printing is an additive manufacturing process. This technology provides us with the opportunity to create 3D structures by adding…

Hide and Seek: The Game Between Chronic Lymphocytic Leukaemia Cells and B Cell Receptor Signalling Inhibitors

The emergence of B cell receptor (BCR) kinase inhibitors has recently changed the treatment landscape in chronic lymphocytic leukaemia (CLL). The…

Haemangioma: A Review of the Literature and an Unusual Case Report

Haemangiomas are benign tumours growing by vascular endothelial hyperplasia, commonly occurring in females.

Transcatheter Repair of Congenital Heart Defects in the Young

In recent decades, tremendous medical advances have been made. Therapeutic cardiac catheterisation for repair of congenital heart defects has become the…

Anaesthesia Techniques in Transfemoral Transcatheter Aortic Valve Implantation: A Brief Review

Transcatheter aortic valve implantation (TAVI) is an alternative, less invasive method to use for aortic valve replacement in high-risk patients. This…

New Drug Treatments for Osteoarthritis: What Is on the Horizon?

Osteoarthritis (OA) is the most common form of arthritis, yet has historically lagged far behind rheumatoid arthritis in terms of drug development.

Contemporary Drug-Eluting Stents and Vascular Response

Cardiovascular disease is a leading cause of death and disability worldwide. Current treatment strategies aimed at treating the consequences of coronary…

Does Race/Ethnicity Have a Role in a Link Between Lower Urinary Tract Symptoms and Metabolic Syndrome?

Metabolic syndrome (MS) is a highly prevalent disease related to the risk of cardiovascular disease and diabetes. A large body of evidence has suggested…

Antiphospholipid Syndrome and the Lungs

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterised by recurrent thromboembolic events (arterial or venous) and/or morbidity…

Cardiovascular Risk Factor Control in Type 2 Diabetes Mellitus and New Trial Evidence

The micro and macrovascular complications of Type 2 diabetes mellitus are influenced by several well described cardiovascular risk factors such as…